The clinical spectrum and pathogenesis of paraneoplastic disorders of the central nervous system

Hematology/Oncology Clinics of North America

Volumn 15, Issue 6, 2001, Pages 1109-1128

  Rosenfeld, Myrna R ^a   Dalmau, Josep ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0035211921     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70270-7     Document Type: Article

References (120)

1. Epitope recognition of recoverin in cancer associated retinopathy: Evidence for calcium-dependent conformational epitopes
2. Role of anti-recoverin autoantibodies in cancerassociated retinopathy
3. Limbic encephalitis and small cell lung cancer - Clinical and immunological features
4. Tumor-specific killer cells in paraneoplastic cerebellar degeneration
5. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: A distinct paraneoplastic syndrome
6. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer
7. Paraneoplastic cerebellar degeneration: Clinical-immunological correlations
8. Clinical course and response to immunotherapy in 24 patients with idiopathic or paraneoplastic opsoclonus-myoclonus syndrome
9. Stiffman syndrome: A rare paraneoplastic disorder?
10. Cell-mediated auto-immunity in paraneoplastic neurologic syndromes with anti-Hu antibodies
11. Paraneoplastic night blindness with malignant melanoma
12. Paraneoplastic syndromes
13. Paraneoplastic optic neuritis and encephalomyelitis
14. Subacute cerebellar degeneration associated with neoplasms
15. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma
16. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system
17. The onconeural antigen Nova-1 is a neuronspecific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies
18. An antineuronal autoantibody in paraneoplastic opsoclonus
19. Autoimmunity to gephyrin in stiff-man syndrome
20. Small cell carcinoma of the endometrium with associated ocular paraneoplastic syndrome
21. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects: A developmental-genetic analysis
22. The distinctive clinical features of paraneoplastic sensory neuronopathy
23. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies
24. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity
25. "Limbic encephalitis" and its association with carcinoma
26. Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma
27. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - A quantitative Western blot analysis
28. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer
29. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: A clinical study of 71 patients
30. Ma1, a novel neuronal and testis specific protein, is recognized by the serum of patients with paraneoplastic neurologic disorders
31. Paraneoplastic syndromes affecting the nervous system
32. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals
33. Autoimmunity in stiff-man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161
34. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer
35. Opsoclonus in adults: Report of three cases and review of the literature
36. Paraneoplastic encephalomyelitis
37. Paraneoplastic opsoclonus-myoclonus: Association with medullary thyroid carcinoma and review of the literature
38. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration
39. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: An association with type I anti-neuronal nuclear antibodies
40. Antineuronal (anti-Ri) antibodies in a patient with steroid responsive opsoclonus-myoclonus
41. The photoreceptor cell-specific nuclear receptor (PNR) is an autoantigen of paraneoplastic retinopathy
42. Paraneoplastic retinopathy associated with uterine sarcoma
43. Meiosis-specific RNA splicing in yeast
44. The steroid and thyroid hormone receptor superfamily
45. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration
46. Anti-Hu antineuronal antibody in neuroblastomaassociated opsoclonus-myoclonus syndrome
47. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer
48. Motor neuron syndromes in cancer patients
49. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration
50. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes
51. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration
52. Anti-GABAergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia
53. Recoverin mediates the calcium effect upon rhodopsin phosphorylation and cGMP hydrolysis in bovine retina rod cells
54. Anti-Hu associated paraneoplastic encephalomyelitis: Analysis of a series of 200 patients
55. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer
56. Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival
57. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease
58. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis
59. The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons
60. The effect of recoverin-like calcium-binding proteins on the photoresponse of retinal rods
61. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma
62. Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings, and tumor association in 50 patients
63. Autoimmune retinopathy: Patients with antirecoverin immunoreactivity and panretinal degeneration
64. Axonal guidance mutants of Caenorhabditis elegans identified by filling sensory neurons with fluorescein dyes
65. Encephalomyelitis with carcinoma
66. POP66, a paraneoplastic encephalomyelitisrelated antigen, is a marker of adult oligodendrocytes
67. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes
68. A clinical triad to diagnose paraneoplastic retinopathy
69. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen
70. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis
71. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor
72. Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3′ UTR of mRNA encoding the Id transcriptional repressor
73. Enteric neuronal autoantibodies in pseudo-obstruction with small-cell lung carcinoma
74. Like attracts like: Getting RNA processing together in the nucleus
75. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
76. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
77. Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA
78. Myoclonic encephalopathy of infants
79. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
80. Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer
81. Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity
82. Hu neuronal proteins are expressed in proliferating neurogenic cells
83. Identification of early neurogenic cells in the neural crest lineage
84. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome
85. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: Differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha
86. Paraneoplastic cerebellar degeneration: I. A clinical analysis of 55 anti-Yo antibody-positive patients
87. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy
88. Molecular cloning of a new unc-33-like cDNA from rat brain and its relation to paraneoplastic neurological syndromes
89. Autoimmune paraneoplastic cerebellar degeneration: Ultrastructural localization of antibody-binding sites in Purkinje cells
90. Encephalomyelitis and carcinomatous neuropathy
91. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration
92. Blindness caused by photoreceptor degeneration as a remote effect of cancer
93. A morphometric study of the cerebellar cortex from patients with carcinoma: A contribution on quantitative aspects in carcinotoxic cerebellar atrophy
94. Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing
95. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor
96. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins
97. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome
98. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal
99. MAP-1: A novel pro-apoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains
100. Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody
101. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody
102. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells
103. Cancer-associated retinopathy
104. The cancer-associated retinopathy antigen is a recoverin-like protein
105. Cerebellar degeneration with Hodgkin's disease: An immunological study
106. Paraneoplastic encephalomyelitis and subacute dysautonomia due to an occult atypical carcinoid tumour of the lung
107. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration
108. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays
109. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis
110. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer
111. Neuromyotonia and bronchial carcinoma
112. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes
113. Recoverin-associated retinopathy: A clinically and immunologically distinctive disease
114. Progressive encephalomyelitis with rigidity
115. Immunofluorescent detection of antibodies against neurons in sensory carcinomatous neuropathy
116. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia
117. CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma related autoimmunity
118. Paraneoplastic encephalomyeloneuritis obscured by coma